1. Home
  2. KR vs GEHC Comparison

KR vs GEHC Comparison

Compare KR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kroger Company (The)

KR

Kroger Company (The)

N/A

Current Price

$61.57

Market Cap

34.9B

ML Signal

N/A

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

N/A

Current Price

$63.98

Market Cap

27.9B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KR
GEHC
Founded
1883
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Computer Software: Prepackaged Software
Sector
Consumer Staples
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.9B
27.9B
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
KR
GEHC
Price
$61.57
$63.98
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$74.25
$88.38
AVG Volume (30 Days)
6.2M
2.6M
Earning Date
03-05-2026
04-29-2026
Dividend Yield
2.09%
0.24%
EPS Growth
N/A
4.84
EPS
1.46
0.85
Revenue
$147,642,000,000.00
$20,625,000,000.00
Revenue This Year
$4.39
$7.12
Revenue Next Year
$2.30
$4.45
P/E Ratio
$42.67
$75.38
Revenue Growth
0.35
4.84
52 Week Low
$54.15
$58.75
52 Week High
$76.58
$89.77

Technical Indicators

Market Signals
Indicator
KR
GEHC
Relative Strength Index (RSI) 67.57 29.33
Support Level $61.17 $60.17
Resistance Level $64.44 $65.83
Average True Range (ATR) 1.51 1.50
MACD 0.43 -1.07
Stochastic Oscillator 96.44 7.72

Price Performance

Historical Comparison
KR
GEHC

About KR Kroger Company (The)

Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 78% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: